A mechanistic model for prediction of metastatic relapse in early-stage breast cancer using routine clinical features - INRIA - Institut National de Recherche en Informatique et en Automatique Accéder directement au contenu
Communication Dans Un Congrès Année : 2022

A mechanistic model for prediction of metastatic relapse in early-stage breast cancer using routine clinical features

Résumé

Estimation of the risk of metastatic relapse is a major challenge to decide treatment options for early-stage breast cancer patients. To date, metastasis free survival (MFS) analysis mainly relies on classical - agnostic - statistical models (e.g., Cox regression). Instead, we propose to derive mechanistic models to predict MFS. The data consisted of patients who did not receive adjuvant systemic therapy from two databases: one (data 1, N = 163) with routine clinical features and the PAI-1 and uPA biomarkers and two (data 2, N = 692) with 11 routine clinical features. The mathematical models are based on a partial differential equation describing a size-structured population of metastases. They predict MFS from the size of the tumor at diagnosis and two mathematical parameters, α and μ describing respectively the tumor growth speed and metastatic dissemination potential. Using mixed-effects modeling, the population distributions of α and μ were assumed to be lognormal and to depend on routine clinical variables, whereas the observation error was assumed lognormal on the time-to-relapse. Variable selection consisted first in a univariate Wald test for all covariates with effect either on α or μ. We then used a backward elimination procedure. Significance of the covariates in the final model was assessed by a multivariable Wald test. Concordance indexes (c-index) were computed to assess the predictive power in cross-validation procedures as well as test sets. The model was implemented as an R package using optimized C++ code for the mechanistic part and enabling parallelization, resulting in a 4-fold reduction of the computing compared to a former python implementation. Nevertheless, over 4 hours are still needed to run a 100 samples bootstrap on a distributed computing cluster. The model selection procedure on data 1 revealed an association of PAI1 and age with μ, and of Estrogen receptor level with alpha, consistent with the established biological link between PAI-1 and tumor invasiveness. The resulting model achieved good prediction performances with a c-index of 0.72 in 5 folds cross-validation. Using only routine clinical markers, the algorithm on data 2 selected a model with the grade and Progesterone Receptors in α, Ki67 and node status in μ. These were able to adequately describe the data on calibration plots but performed poorly in prediction with a cross validated c-index of 0.60. Mechanistic modeling was able to unravel the biological and predictive role of PAI-1 but showed limited predictive power when using only on routine clinical features.
Fichier principal
Vignette du fichier
2022_AACR_poster_landscape.pdf (591.05 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03752407 , version 1 (16-08-2022)

Identifiants

Citer

Célestin Bigarré, Pascal Finetti, François Bertucci, Xavier Muracciole, Sébastien Benzekry. A mechanistic model for prediction of metastatic relapse in early-stage breast cancer using routine clinical features. AACR, Apr 2022, New Orléans, United States. pp.2737, ⟨10.1158/1538-7445.AM2022-2737⟩. ⟨hal-03752407⟩
98 Consultations
36 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More